tiger accelerator logo square_edited.jpg

Dr. Wen-Chin Yang

Pavilion:
National Biotechnology Research Park (BioTReC research group)
Industry:
Pharmaceutical, Metabolic Disease T2D

About

First-in-class small-molecule drugs to reverse type two diabetes (T2D)